NCT04955990 A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants Status TERMINATED Phase PHASE4
NCT04930289 Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs Status ENROLLING_BY_INVITATION Phase N/A
NCT04908397 Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1
NCT04903730 Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution Status COMPLETED Phase PHASE1
NCT04896008 A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH) Status COMPLETED Phase PHASE3
NCT04884971 Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study Status COMPLETED Phase PHASE1
NCT04816604 Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04813926 A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) Status COMPLETED Phase N/A
NCT04811092 Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) Status TERMINATED Phase PHASE3
NCT04808830 Prevalence of Musculoskeletal Pain and Its Impact on Quality of Life and Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT04796337 A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04791514 A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE2
NCT04787445 Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT04732221 A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) Status COMPLETED Phase PHASE2/PHASE3
NCT04712669 A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) Status COMPLETED Phase PHASE2
NCT04691154 A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD Status ACTIVE_NOT_RECRUITING Phase PHASE3